↓ Skip to main content

Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy

Overview of attention for article published in BMC Cancer, April 2009
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
21 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy
Published in
BMC Cancer, April 2009
DOI 10.1186/1471-2407-9-132
Pubmed ID
Authors

Shadi Mamaghani, Satish Patel, David W Hedley

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 5%
Unknown 20 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 19%
Researcher 4 19%
Student > Postgraduate 4 19%
Student > Master 3 14%
Student > Doctoral Student 3 14%
Other 2 10%
Unknown 1 5%
Readers by discipline Count As %
Agricultural and Biological Sciences 9 43%
Medicine and Dentistry 3 14%
Biochemistry, Genetics and Molecular Biology 2 10%
Pharmacology, Toxicology and Pharmaceutical Science 2 10%
Chemistry 2 10%
Other 1 5%
Unknown 2 10%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 May 2018.
All research outputs
#3,799,080
of 12,920,212 outputs
Outputs from BMC Cancer
#1,040
of 4,805 outputs
Outputs of similar age
#99,776
of 259,911 outputs
Outputs of similar age from BMC Cancer
#1
of 2 outputs
Altmetric has tracked 12,920,212 research outputs across all sources so far. This one is in the 49th percentile – i.e., 49% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,805 research outputs from this source. They receive a mean Attention Score of 4.0. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 259,911 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them